4Indexed trials
drug · Product Intelligence
Ramelteon
Pipeline Intelligence
Ramelteon: 4 indexed trials, 3 sponsors; 0 linked Orange Book patents and 12 FDA-linked events where matched.
3Sponsors
0Orange Book patent links
12FDA-linked events
Development evidence
NCT00325728Takeda · alzheimersPHASE2
NCT00622427University of Alabama at Birmingham · adhdPHASE4
NCT02669082Takeda · depressionPHASE4
NCT07382843Tri-Service General Hospital (TSGH) · other_neurologyPHASE4
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALRAMELTEON · 2026-06-04
FDA_APPROVALRAMELTEON · 2023-07-10
FDA_APPROVALRAMELTEON · 2023-02-09
FDA_APPROVALRAMELTEON · 2022-11-25
FDA_APPROVALRAMELTEON · 2022-08-24
FDA_APPROVALRAMELTEON · 2020-10-26
FDA_APPROVALRAMELTEON · 2020-08-21
FDA_APPROVALRAMELTEON · 2020-04-10
FDA_APPROVALRAMELTEON · 2019-07-22
FDA_APPROVALRAMELTEON · 2015-08-19
FDA_APPROVALRAMELTEON · 2013-07-26
FDA_APPROVALROZEREM · 2005-07-22
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.